iSpecimen Inc. (ISPC) stock
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value
$0.71−0.03 (-3.81%)
Close on Nov 11, 2026Market cap $1.79MP/E –Yield –
iSpecimen ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
iSpecimen's ebitda for the twelve months ending Jun 30, 2026 was -$8.22M. For fiscal 2025 it was -$7.25M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.25M | – |
| FY2024 | Dec 31, 2024 | -$10.43M | – |
| FY2023 | Dec 31, 2023 | -$9.05M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.40M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.28M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.37M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.39M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.21M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.29M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.57M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.40M | – |
See a number that looks wrong?